Pressestimmen
From the reviews: “This comprehensive book addresses the pathophysiology, assessment, clinical course, and contemporary management of patients with valvular heart disease. … This book is geared toward cardiologists, cardiac surgeons, and physicians in training involved in the diagnosis and management of valvular heart disease. … Both black-and-white and color illustrations include hemodynamic tracings and echocardiographic and pathologic images. This is an easy to read, comprehensive, and up-to-date resource for physicians involved in the management of patients with valvular heart disease.” (Yabiz Sedghi, Doody’s Review Service, February, 2010) “This book, written by cardiologists, cardiac surgeons and researchers from renowned American and Canadian centres, gives insight into the pathology, the haemodynamics and the clinic related to the morphological and functional conditions of the heart valves, and into the current management of heart valve disease patients. … The books reads easily. All aspects of valvular heart disease are covered widely. … For everyone involved in caring for valvular heart disease patients this book offers a broad perspective.” (Tine De Backer, Acta Clinica Belgica, Vol. 65 (5), 2010)
Kurzbeschreibung
Challenges for the treatment of valvular heart disease include the growing need for effective yet less invasive interventions and therapies to treat these progressive conditions. With the development of potential new treatments, it is crucial for cardiac physicians to be well informed on the pathophysiology, assessment, treatment options and their outcomes of valvular diseases. Written by a highly experienced and internationally recognized group of cardiologists, cardiac surgeons, and researchers, Valvular Heart Disease offers insights into the widely varying hemodynamic effects and clinical course of heart valve conditions, as well as the contemporary management of these conditions. Offering a broad perspective on these diseases, Valvular Heart Disease expands on the recent guidelines developed by the major heart societies in the United State and Europe.
